Article addresses role of advocacy in advancing healthy vision to meet Sustainable Development Goals DALLAS, Aug. 9, 2022 /PRNewswire/ -- OneSight EssilorLuxottica Foundation (Foundation) is pleased to announce the publication ...
NEW DELHI , Aug. 3, 2022 /PRNewswire/ -- Award-winning and bestselling author of The Last Queen and The Forest of Enchantments Chitra Banerjee Divakaruni publishes her most ambitious novel to date. ...
Intratumoral injection of allogeneic pro-inflammatory dendritic cells (“ilixadencel”) substantially and sustainably enhanced an otherwise ineffective systemic anti CTLA-4 treatment in an established in vivo cancer modelEffects were shown to be ...
- The Lancet Regional Health Southeast Asia publishes the successful phase 3 clinical trial results of Nitric Oxide Nasal Spray. - Phase 3 trial of Nitric Oxide Nasal Spray administered ...
ZURICH, Switzerland, June 10, 2022 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (SIX: ACHI; OTCQB: ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”) announces that Achiko ...
Orphazyme A/SCompany announcementNo. 30/2022 ...
HIGH POINT, N.C., June 04, 2022 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical company focused on the development of orally administered treatments for type 1 ...
DENVER--(BUSINESS WIRE)--(NYSE: AIV) - Apartment Investment and Management Company, known as Aimco, has been selected as a 2022 Healthiest Employer by both The Denver and South Florida Business Journals. Aimco ...
NEW YORK, May 31, 2022 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, ...
Emerald study met both its primary end points of Progression-free survival (PFS) in overall population and in ESR1 mutated patientsPFS rate at 12 months with elacestrant was 22.32% vs. 9.42% ...
Copyright © 2015 - 2021 Lifecarenews.in
